Trials / Completed
CompletedNCT01056835
Effects of PGI2 Analogue Use on the Development of Chronic Allograft Nephropathy
- Status
- Completed
- Phase
- Phase 3
- Study type
- Interventional
- Enrollment
- 40 (estimated)
- Sponsor
- Seoul National University Hospital · Academic / Other
- Sex
- All
- Age
- 20 Years – 50 Years
- Healthy volunteers
- Not accepted
Summary
The purpose of this study is to evaluate the effect of Prostaglandin I2 analogue use on the development of chronic allograft nephropathy and changes in allograft function in prevalent renal transplant recipients
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| DRUG | prostaglandin I2 analogue |
Timeline
- Start date
- 2009-06-01
- Primary completion
- 2013-12-01
- Completion
- 2014-06-01
- First posted
- 2010-01-26
- Last updated
- 2015-05-27
Locations
1 site across 1 country: South Korea
Source: ClinicalTrials.gov record NCT01056835. Inclusion in this directory is not an endorsement.